المؤلفون: Frankel J, Staskin D, Varano S, Kennelly MJ, Jankowich RA, Haag-Molkenteller C

المصدر: Therapeutics and Clinical Risk Management, Vol Volume 18, Pp 171-182 (2022)

مصطلحات موضوعية: adrenergic agonist, β-adrenergic receptor, urinary bladder, overactive, urinary incontinence, vibegron, Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

Relation: https://www.dovepress.com/an-evaluation-of-the-efficacy-and-safety-of-vibegron-in-the-treatment--peer-reviewed-fulltext-article-TCRM; https://doaj.org/toc/1178-203X

URL الوصول: https://doaj.org/article/3d61f8cffc004715bd799b984dca47e8

المؤلفون: Staskin D; Tufts University School of Medicine, Boston, MA, USA., Frankel J; Seattle Urology Research Center, Seattle, WA, USA., Varano S; Clinical Research Consulting, Milford, CT, USA., Kennelly M; Carolinas Medical Center, Charlotte, NC, USA., Newman DK; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Rosenberg MT; Mid-Michigan Health Centers, Jackson, MI, USA., Shortino DD; Urovant Sciences, Irvine, CA, USA., Jankowich RA; Urovant Sciences, Irvine, CA, USA., Mudd PN Jr; Urovant Sciences, Irvine, CA, USA.

المصدر: International journal of clinical practice [Int J Clin Pract] 2022 Apr 13; Vol. 2022, pp. 6475014. Date of Electronic Publication: 2022 Apr 13 (Print Publication: 2022).

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Hindawi Country of Publication: India NLM ID: 9712381 Publication Model: eCollection Cited Medium: Internet ISSN: 1742-1241 (Electronic) Linking ISSN: 13685031 NLM ISO Abbreviation: Int J Clin Pract Subsets: MEDLINE

مواضيع طبية MeSH: Urinary Bladder, Overactive*/complications , Urinary Bladder, Overactive*/drug therapy, Double-Blind Method ; Humans ; Pyrimidinones ; Pyrrolidines ; Tolterodine Tartrate/therapeutic use ; Treatment Outcome ; Urinary Incontinence, Urge

المؤلفون: Frankel J; Seattle Urology Research Center, Seattle, WA, USA., Staskin D; Tufts University School of Medicine, Boston, MA, USA., Varano S; Clinical Research Consulting, Milford, CT, USA., Kennelly M; Carolinas Medical Center, Charlotte, NC, USA., Newman DK; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Rosenberg MT; Mid-Michigan Health Centers, Jackson, MI, USA., Jankowich RA; Urovant Sciences, Irvine, CA, USA., Shortino D; Urovant Sciences, Irvine, CA, USA., Mudd PN Jr; Urovant Sciences, Irvine, CA, USA., Girman CJ; CERobs Consulting, LLC, 2612 Lumina Avenue North, Wrightsville Beach, Chapel Hill, NC, 28480, USA. cindy.girman@cerobs.com.

المصدر: Advances in therapy [Adv Ther] 2022 Feb; Vol. 39 (2), pp. 959-970. Date of Electronic Publication: 2021 Dec 18.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther

مواضيع طبية MeSH: Urinary Bladder, Overactive*/drug therapy, Double-Blind Method ; Humans ; Muscarinic Antagonists/therapeutic use ; Pyrimidinones/therapeutic use ; Pyrrolidines ; Treatment Outcome